Sense Relief has received an innovation grant from the UCSF-Stanford Pediatric device consortium for its technical development and clinical study of an anthemic digital therapeutic based on the Apple Watch.
Many studies over the years have shown the benefits of acupressure therapy for treating nausea and morning sickness.
- Apple Health is not TikTok, and other conversations with Dr. Oliver Aalami (post-WWDC Insight Series)
- Alertgy’s noninvasive CGM (glucose monitoring) wristband, DeepGluco shows promise in a new study
- Revibe Technologies, maker of a smartwatch for ADHD and Autism secures $3 million in funding
Sense Relief uses the Apple Watch to deliver acupressure therapy to ease symptoms of nausea and vomiting, including motion sickness, and hangover-related nausea. The initial focus is on pregnancy-related nausea and vomiting, or “morning sickness,” since two-thirds of current users are pregnant women.
The Sense Relief app is available for download to the Apple Watch to help ease symptoms of nausea.
The study will help determine the advantages of this new treatment method, understand usage patterns, and classify the causes of nausea, such as medication-induced nausea, stress-related nausea, and vestibular neuritis.
The Sense Relief team plans to optimize a more effective personalized treatment for nausea with wearable health technology and use a data-driven approach to investigate other maternal health issues. “We believe that with the data collected through wearable sensors we can apply predictive analytics to create digital medical software that can detect early warning signs of preterm labor and preeclampsia, which will be a major advancement in maternal health,” according to co-founder Matt Bucklin.
Sense Relief will use Stanford’s Byers Center for Biodesign CardinalKit to support the ongoing consumer study of thousands of Sense Relief users.
Source: Sense Relief Press Release